|
| ||||||||||||||
CORRECTION -- Generex Biotechnology to Make Convertible Debenture Payment in Cash WORCESTER, Mass., Nov. 12, 2008 (GLOBE NEWSWIRE) -- In a
release issued earlier today by Generex Biotechnology Corporation
(NasdaqCM:GNBT - News) (http://www.generex.com), under the same headline,
note that in the third paragraph Rose Perri was mistakenly
identified as the Company's Chief Executive Officer. Perri
is the Company's Chief Financial Officer. Contact: CEOcast, Inc.
Gary Nash
212-732-4300
American Capital Ventures, Inc.
Howard Gostfrand
1-877-918-0774
Source: Generex Biotechnology Corp.
|  | |||||||||||||
